Premium
Racial variations in COVID‐19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti‐androgens a potential treatment for COVID‐19?
Author(s) -
McCoy John,
Wambier Carlos G.,
VanoGalvan Sergio,
Shapiro Jerry,
Sinclair Rodney,
Ramos Paulo Müller,
Washenik Kenneth,
Andrade Murilo,
Herrera Sabina,
Goren Andy
Publication year - 2020
Publication title -
journal of cosmetic dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.626
H-Index - 44
eISSN - 1473-2165
pISSN - 1473-2130
DOI - 10.1111/jocd.13455
Subject(s) - tmprss2 , prostate cancer , population , androgen receptor , mortality rate , biology , medicine , physiology , cancer , disease , demography , covid-19 , environmental health , infectious disease (medical specialty) , sociology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom